Category: elsevier

Without “confidence in the conclusions,” group retracts prostate cancer paper

redjournalBack in January, we wrote about the retraction of a paper in the International Journal of Radiation Oncology *Biology* Physics, the first from that journal in its 38-year history.

At the time, the journal’s new editor, Anthony Zietman, of Mass General, told us that he was working on a second retraction. That one has arrived.

The paper, “High-Dose Conformal Radiotherapy Reduces Prostate Cancer–Specific Mortality: Results of a Meta-analysis,” came from a team of radiation oncologists in Brazil, and was published last August.

According to the retraction notice:

Continue reading Without “confidence in the conclusions,” group retracts prostate cancer paper

Markets crash, and so does a paper explaining why

j financial marketsMarkets undergo flash crashes — when stocks or bonds rapidly nosedive in value and then just as rapidly recover — every day. On May 6, 2010, for example, the entire equity market flamed out and then nearly recovered its value all in the matter of hours.

Economic papers can do the same, apparently. Take the recent withdrawal of an paper from the Journal of Financial Markets: Continue reading Markets crash, and so does a paper explaining why

Misuse of data forces retraction of paper on sow’s milk

jchrombA group of veterinary researchers from Taiwan has lost their 2012 paper in the Journal of Chromatography B for misuse of propriety material.

What that means we’re not quite sure, but we have a guess.

The article, “Pilot production of recombinant human clotting factor IX from transgenic sow milk,” was published last July by four scientists at the Animal Technology Institute of Taiwan.

But, as the retraction notice explains, the paper didn’t stick:

Continue reading Misuse of data forces retraction of paper on sow’s milk

Trial irregularities earn Lancet study of potential weight loss drug tesofensine Expression of Concern

logo_lancetA potential weight loss drug has been dealt what could be a serious setback after regulators found problems at two trial sites.

While awaiting a final report, The Lancet, which published a study of the drug, tesofensine, has issued an Expression of Concern: Continue reading Trial irregularities earn Lancet study of potential weight loss drug tesofensine Expression of Concern

Vacuum retracts paper on nanorods for plagiarism, image manipulation

vacuumWhat’s that sucking sound you hear from the journal Vacuum? Why, a retraction, of course.

The journal is pulling a 2012 paper by a group of researchers from India who stole images and used them in misleading ways — that’s data fabrication, kids.

Here’s the retraction notice for the article, titled “Microwave synthesis, characterization and humidity sensing properties of single crystalline Zn2SnO4 nanorods”:

Continue reading Vacuum retracts paper on nanorods for plagiarism, image manipulation

Arsenic-in-the-water paper with “interesting data” first corrected, now retracted

jchcoverNote (4/9/13): John McArthur contacted us with a few corrections, which we have made below.

The Journal of Contaminant Hydrology has retracted a 2008 paper by a group of Indian scientists for plagiarism and the failure to adequately reference their sources.

What makes this case somewhat unusual is that the journal allowed the authors to issue a correction (of the mega variety) attempting to acknowledge the problems, but then evidently decided that the patient was too sick to live — and that part of the disease was iatrogenic.

Here’s the retraction notice for the article, titled “Hydrogeochemical behavior of arsenic-enriched groundwater in the deltaic environment: Comparison between two study sites in West Bengal, India”:

Continue reading Arsenic-in-the-water paper with “interesting data” first corrected, now retracted

Second retraction appears for University of Wisconsin neuroscientist who faked images

brain researchA University of Wisconsin scientist who was found by the Office of Research Integrity (ORI) to have faked data in two papers, has had a second study retracted.

Here’s the notice: for “Secretory phospholipase A2 IIA is up-regulated by TNF-α and IL-1α/β after transient focal cerebral ischemia in rat,” by Rao Adibhatla and colleagues and originally published in Brain Research in February 2007: Continue reading Second retraction appears for University of Wisconsin neuroscientist who faked images

Frequent Retraction Watch fliers rack them up: Stapel hits 51, Lichtenthaler scores number 9

freq flyer
Rewards may vary

Quick updates on work by two people whose names appear frequently on Retraction Watch: Diederik Stapel and Ulrich Lichtenthaler.

Last month, we reported on the 50th retraction for Stapel. Here’s number 51 in the Journal of Experimental Social Psychology, for “The flexible unconscious: Investigating the judgmental impact of varieties of unaware perception:” Continue reading Frequent Retraction Watch fliers rack them up: Stapel hits 51, Lichtenthaler scores number 9

Retraction for water researchers who ripped off dissertation

JCAMcoverA pair of engineers at Hohai University in Nanjing, China, has lost their 2012 paper in the Journal of Computational and Applied Mathematics. The reason: The article, “Study of the New Leon model for concrete failure,” wasn’t theirs to publish.

According to the retraction notice (which is dated September 2013 but has already appeared in ScienceDirect): Continue reading Retraction for water researchers who ripped off dissertation

New Mexico obstetrics researcher violated research subject protocols: Retraction notice

gynoncLaurence Cole, an obstetrics researcher at the University of New Mexico, made an appearance on this blog in November 2011 after the American Journal of Obstetrics & Gynecology published a remarkably heavy-handed retraction of one of his papers.

Shortly after, we learned that the retraction was preceded by a strongly-worded letter from an attorney representing a company that had been miffed by the content of Cole’s article (the issue involved the effectiveness of commercially-available pregnancy tests, and Cole’s failure to adequately disclose a past relationship with the aggrieved company’s competitor). That letter read, in part: Continue reading New Mexico obstetrics researcher violated research subject protocols: Retraction notice